标题
Engineered IL-10 variants elicit potent immunomodulatory effects at low ligand doses
作者
关键词
-
出版物
Science Signaling
Volume 13, Issue 649, Pages eabc0653
出版商
American Association for the Advancement of Science (AAAS)
发表日期
2020-09-16
DOI
10.1126/scisignal.abc0653
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Mechanism of homodimeric cytokine receptor activation and dysregulation by oncogenic mutations
- (2020) Stephan Wilmes et al. SCIENCE
- Pegilodecakin combined with pembrolizumab or nivolumab for patients with advanced solid tumours (IVY): a multicentre, multicohort, open-label, phase 1b trial
- (2019) Aung Naing et al. LANCET ONCOLOGY
- A strategy for the selection of monovalent antibodies that span protein dimer interfaces
- (2019) Jamie B. Spangler et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Biology and therapeutic potential of interleukin-10
- (2019) Margarida Saraiva et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Immune regulation and cytotoxic T cell activation of IL-10 agonists – Preclinical and clinical experience
- (2019) Martin Oft SEMINARS IN IMMUNOLOGY
- Kinetics of cytokine receptor trafficking determine signaling and functional selectivity
- (2019) Jonathan Martinez-Fabregas et al. eLife
- Epigenomic-Guided Mass Cytometry Profiling Reveals Disease-Specific Features of Exhausted CD8 T Cells
- (2018) Bertram Bengsch et al. IMMUNITY
- Interleukin-2 shapes the cytotoxic T cell proteome and immune environment–sensing programs
- (2018) Christina M. Rollings et al. Science Signaling
- Interleukin-2 shapes the cytotoxic T cell proteome and immune environment–sensing programs
- (2018) Christina M. Rollings et al. Science Signaling
- The Dynamics of Interleukin-10-Afforded Protection during Dextran Sulfate Sodium-Induced Colitis
- (2018) Ana Cardoso et al. Frontiers in Immunology
- PEGylated IL-10 (Pegilodecakin) Induces Systemic Immune Activation, CD8+ T Cell Invigoration and Polyclonal T Cell Expansion in Cancer Patients
- (2018) Aung Naing et al. CANCER CELL
- CML hematopoietic stem cells expressing IL-1RAP can be targeted by chimeric antigen receptor (CAR)-engineered T cells
- (2018) Walid Warda et al. CANCER RESEARCH
- The IFN-λ-IFN-λR1-IL-10Rβ Complex Reveals Structural Features Underlying Type III IFN Functional Plasticity
- (2017) Juan L. Mendoza et al. IMMUNITY
- Anti-inflammatory effect of IL-10 mediated by metabolic reprogramming of macrophages
- (2017) W. K. Eddie Ip et al. SCIENCE
- Ligand-induced type II interleukin-4 receptor dimers are sustained by rapid re-association within plasma membrane microcompartments
- (2017) David Richter et al. Nature Communications
- Applications of Genetically Modified Immunobiotics with High Immunoregulatory Capacity for Treatment of Inflammatory Bowel Diseases
- (2017) Suguru Shigemori et al. Frontiers in Immunology
- The paradoxical role of IL-10 in immunity and cancer
- (2015) Mark H. Mannino et al. CANCER LETTERS
- Tuning Cytokine Receptor Signaling by Re-orienting Dimer Geometry with Surrogate Ligands
- (2015) Ignacio Moraga et al. CELL
- Suppression of antigen presentation by IL-10
- (2015) Sharad K Mittal et al. CURRENT OPINION IN IMMUNOLOGY
- Interleukin-10 paradox: A potent immunoregulatory cytokine that has been difficult to harness for immunotherapy
- (2015) Ankit Saxena et al. CYTOKINE
- Receptor dimerization dynamics as a regulatory valve for plasticity of type I interferon signaling
- (2015) Stephan Wilmes et al. JOURNAL OF CELL BIOLOGY
- Instructive roles for cytokine-receptor binding parameters in determining signaling and functional potency
- (2015) Ignacio Moraga et al. Science Signaling
- Instructive roles for cytokine-receptor binding parameters in determining signaling and functional potency
- (2015) Ignacio Moraga et al. Science Signaling
- Serum IL-10 Predicts Worse Outcome in Cancer Patients: A Meta-Analysis
- (2015) Shuai Zhao et al. PLoS One
- Evidence for non-neutralizing autoantibodies against IL-10 signalling components in patients with inflammatory bowel disease
- (2014) Natalie Frede et al. BMC IMMUNOLOGY
- The activating effect of IFN-γ on monocytes/macrophages is regulated by the LIF–trophoblast–IL-10 axis via Stat1 inhibition and Stat3 activation
- (2014) Angham Dallagi et al. Cellular & Molecular Immunology
- Transcription Factor STAT3 and Type I Interferons Are Corepressive Insulators for Differentiation of Follicular Helper and T Helper 1 Cells
- (2014) John P. Ray et al. IMMUNITY
- Interleukin-10 Receptor Signaling in Innate Immune Cells Regulates Mucosal Immune Tolerance and Anti-Inflammatory Macrophage Function
- (2014) Dror S. Shouval et al. IMMUNITY
- IL-10: Master Switch from Tumor-Promoting Inflammation to Antitumor Immunity
- (2014) M. Oft Cancer Immunology Research
- Pegylated IL-10 induces cancer immunity
- (2013) John B. Mumm et al. BIOESSAYS
- IL-10 Directly Activates and Expands Tumor-Resident CD8+ T Cells without De Novo Infiltration from Secondary Lymphoid Organs
- (2012) J. Emmerich et al. CANCER RESEARCH
- IL-10 Elicits IFNγ-Dependent Tumor Immune Surveillance
- (2011) John B. Mumm et al. CANCER CELL
- Opposing regulation of the locus encoding IL-17 through direct, reciprocal actions of STAT3 and STAT5
- (2011) Xiang-Ping Yang et al. NATURE IMMUNOLOGY
- Defective IL-10 production in severe phenotypes of Crohn's disease
- (2009) Ismael Correa et al. JOURNAL OF LEUKOCYTE BIOLOGY
- Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources
- (2009) Da Wei Huang et al. Nature Protocols
- Modulation of protein properties in living cells using nanobodies
- (2009) Axel Kirchhofer et al. NATURE STRUCTURAL & MOLECULAR BIOLOGY
- Molecular and Structural Basis of Cytokine Receptor Pleiotropy in the Interleukin-4/13 System
- (2008) Sherry L. LaPorte et al. CELL
- Dynamic multiple-target tracing to probe spatiotemporal cartography of cell membranes
- (2008) Arnauld Sergé et al. NATURE METHODS
- Bioinformatics enrichment tools: paths toward the comprehensive functional analysis of large gene lists
- (2008) Da Wei Huang et al. NUCLEIC ACIDS RESEARCH
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now